A Study in Healthy Men to Test Whether BI 425809 Influences the Amount of Midazolam in the Blood
Clinical trial NCT05258110 · COMPLETED
Trial details
- NCT number
- NCT05258110
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-18
- Primary completion
- 2022-05-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.